Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$13.19 - $22.1 $771,509 - $1.29 Million
-58,492 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$14.54 - $25.02 $2.55 Million - $4.39 Million
-175,422 Reduced 74.99%
58,492 $1.12 Million
Q3 2021

Nov 12, 2021

BUY
$31.92 - $37.0 $7.47 Million - $8.65 Million
233,914 New
233,914 $7.66 Million

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.